OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
002324$14.4959

Shanghai Pret Composites Co Ltd

Commodity ChemicalsVerified

Shanghai Pret Composites maintains a debt-to-equity ratio of 1.02 and a current ratio of 1.11, indicating moderate liquidity and a balanced short-term financial position. The company's price-to-book ratio of 3.47 and price-to-tangible-book ratio of 3.47 suggest that the market is valuing the company at a premium to its book value, which may reflect expectations of future growth or intangible assets. However, the company's free cash flow is negative at -261.01 million CNY, and capital expenditures are significant at -807.98 million CNY, indicating ongoing investment in operations. Profitability metrics show a return on equity of 7.92% and a return on assets of 2.86%, which are below the typical thresholds for high-performing chemical firms. The company's gross profit margin is 13.82% (1.37 billion CNY gross profit on 9.90 billion CNY revenue), and its operating margin is 3.52% (348.08 million CNY operating income on 9.90 billion CNY revenue), both of which are in line with the industry's median for commodity chemicals. The company's net income of 367.48 million CNY on 9.90 billion CNY revenue yields a net margin of 3.71%, which is modest for the sector. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to regional economic or regulatory risks. The company's exposure to China's domestic market is significant, and its performance is closely tied to local demand and regulatory conditions. Looking ahead, the company's revenue is projected to grow by a modest amount in the current fiscal year, with a slight acceleration expected in the following year. The company's price-to-earnings ratio of 43.86 and enterprise value-to-EBITDA ratio of 59.86 suggest that the market is pricing in long-term growth expectations, despite the company's current profitability levels. The company's capital expenditures and free cash flow dynamics indicate that it is investing in its operations, which may support future revenue expansion. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which may limit its ability to fund operations without external financing. However, the company's low dilution risk suggests that it is not currently issuing shares at a rate that would significantly dilute existing shareholders. The company's debt structure is dominated by long-term debt, which may provide some stability in the short term but could become a concern if interest rates rise. Recent filings and transcripts indicate that the company is focused on maintaining operational efficiency and managing costs in a competitive market. Analysts have assigned a mean price target of 19.70 CNY, with a mean recommendation of 2.00 (Buy), suggesting a generally positive outlook. The company has not disclosed any major strategic shifts or new product launches in recent quarters, and its business model remains centered on commodity chemical production.

30-day price · 002324-1.46 (-9.8%)
Low$13.39High$17.70Close$13.41As of22 May, 00:00 UTC
Profile
CompanyShanghai Pret Composites Co Ltd
Ticker002324.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Shanghai Pret Composites Co Ltd is a Chinese manufacturer of commodity chemicals, primarily generating revenue through the production and sale of chemical products.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Shanghai Pret Composites maintains a debt-to-equity ratio of 1.02 and a current ratio of 1.11, indicating moderate liquidity and a balanced short-term financial position. The company's price-to-book ratio of 3.47 and price-to-tangible-book ratio of 3.47 suggest that the market is valuing the company at a premium to its book value, which may reflect expectations of future growth or intangible assets. However, the company's free cash flow is negative at -261.01 million CNY, and capital expenditures are significant at -807.98 million CNY, indicating ongoing investment in operations. Profitability metrics show a return on equity of 7.92% and a return on assets of 2.86%, which are below the typical thresholds for high-performing chemical firms. The company's gross profit margin is 13.82% (1.37 billion CNY gross profit on 9.90 billion CNY revenue), and its operating margin is 3.52% (348.08 million CNY operating income on 9.90 billion CNY revenue), both of which are in line with the industry's median for commodity chemicals. The company's net income of 367.48 million CNY on 9.90 billion CNY revenue yields a net margin of 3.71%, which is modest for the sector. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to regional economic or regulatory risks. The company's exposure to China's domestic market is significant, and its performance is closely tied to local demand and regulatory conditions. Looking ahead, the company's revenue is projected to grow by a modest amount in the current fiscal year, with a slight acceleration expected in the following year. The company's price-to-earnings ratio of 43.86 and enterprise value-to-EBITDA ratio of 59.86 suggest that the market is pricing in long-term growth expectations, despite the company's current profitability levels. The company's capital expenditures and free cash flow dynamics indicate that it is investing in its operations, which may support future revenue expansion. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which may limit its ability to fund operations without external financing. However, the company's low dilution risk suggests that it is not currently issuing shares at a rate that would significantly dilute existing shareholders. The company's debt structure is dominated by long-term debt, which may provide some stability in the short term but could become a concern if interest rates rise. Recent filings and transcripts indicate that the company is focused on maintaining operational efficiency and managing costs in a competitive market. Analysts have assigned a mean price target of 19.70 CNY, with a mean recommendation of 2.00 (Buy), suggesting a generally positive outlook. The company has not disclosed any major strategic shifts or new product launches in recent quarters, and its business model remains centered on commodity chemical production.
Key takeaways
  • The company's liquidity position is moderate, with a current ratio of 1.11 and a debt-to-equity ratio of 1.02.
  • Profitability metrics are in line with industry medians, but the company's return on equity and return on assets are relatively modest.
  • The company's revenue is concentrated in a single business segment, with no material geographic diversification reported.
  • Analysts have a generally positive outlook, with a mean price target of 19.70 CNY and a mean recommendation of 2.00 (Buy).
  • The company is investing in its operations, as evidenced by significant capital expenditures and a negative free cash flow.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$9.90B
Gross profit$1.37B
Operating income$348.1M
Net income$367.5M
R&D
SG&A
D&A
SBC
Operating cash flow$1.14B
CapEx-$808.0M
Free cash flow-$261.0M
Total assets$12.83B
Total liabilities$8.19B
Total equity$4.64B
Cash & equivalents
Long-term debt$4.72B
Valuation
Market price$14.49
Market cap$16.12B
Enterprise value$20.83B
P/E43.9
Reported non-GAAP P/E
EV/Revenue2.1
EV/Op income59.9
EV/OCF18.3
P/B3.5
P/Tangible book3.5
Tangible book$4.64B
Net cash-$4.72B
Current ratio1.1
Debt/Equity1.0
ROA2.9%
ROE7.9%
Cash conversion3.1%
CapEx/Revenue-8.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002324Activity
Op margin3.5%0.4% medp25 -8.0% · p75 16.0%above median
Net margin3.7%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin13.8%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-8.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity102.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target19.70 CNY
Median price target19.70 CNY
High price target19.70 CNY
Low price target19.70 CNY
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count2.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.47 CNY
Last actual EPS0.34 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 01:05 UTCJob: a665f85a